Clinical Trials

Joining Clinical Trials

To join a current clinical trial or apply for future trials, click on the button that you are interested in to submit your contact information. You will be contacted to determine your eligibility for participation and potential to be compensated for your time and travel if you are accepted into a clinical trial. Patients who participate in clinical trials have access to the most advanced, evidence-based and cutting edge of new treatments that adhere to the highest safety standards. Interested participants do not need to live in the same state where the clinical trial is located.

Atopic Dermatitis
(Eczema)

Atopic Dermatitis, often is referred to as eczema. Eczema refers to multiple different inflammatory rashes. Atopic Dermatitis is a chronic relapsing itchy variant of eczema seen in patients who have, or have family members with “atopy”. Atopy often includes Read Moreother allergy based disorders seen in the patient and/or relatives: asthma, hay fever, and conjunctivitis, sensitivity to foods, wool as well as other skin and systemic findings. For more information: https://www.dermnetnz.org/topics/atopic-dermatitis ; https://www.aad.org/public/diseases/eczema/atopic-dermatitis ; https://nationaleczema.org/

  • Age Group: 18 to 65
  • Ormond Beach, FL
  • Trial Date: August 2018 (Ongoing)

This trial is for patients who are 18 to 65 years of age with moderate to severe atopic dermatitis. It will involve double-blind, randomized, placebo treatments controlled for 147 days.

Join Clinical Trial
  • Age Group: 18 to 75
  • Ormond Beach, FL
  • Trial Date: July 2018 (Ongoing)

This trial is for patients aged 18 to 75 with moderate to severe atopic dermatitis. It involves administering oral medication and double-blind, randomized, placebo treatments controlled for 12 weeks and then an additional year of open-label extension.

Join Clinical Trial

Basal Cell Nevus Syndrome
(Gorlin Syndrome)

  • Age Group: 18 and Older
  • Ormond Beach, FL
  • Trial Date: February 2019 (Ongoing)

This trial is for patients with Basal Cell Carcinoma Nevus Syndrome (Gorlin Syndrome) who are 18 years of age or older. Patients will receive a topical gel to treat their face only for 14 months.

Join Clinical Trial

Acne Scarring

Acne, or acne vulgaris (common) is an inflammatory process with affects tiny hair follicles on the face, chest, back and shoulders affecting over 90 % of teenagers. It is associated with papules (red bumps), pustules, open comedones (black heads) and closed Read Morecomedones (tiny white firm papules). Acne usually resolves during the mid-twenties. In some individuals acne may persist into senior years. Factors proposed to be associated with the severity of and persistence of acne include: tobacco, sun, diets high in cholesterol, use of skin and hair products that promote acne (comedogenic products) and abrasive skin care. Treatment response varies among acne patients; new treatments are under development for those who fail to respond to current treatment. Many patients with acne can develop scarring. This may be associated with trauma to the lesions; but equally occurs spontaneously from the acne process on its own. Treatments for acne scarring are under development. https://www.dermnetnz.org/topics/acne ; https://www.aad.org/public/diseases/acne-and-rosacea/acne ; https://www.aad.org/public/diseases/acne-and-rosacea/acne-scars#treatment; https://acneandrosacea.org/

  • Age Group: 22 and Older
  • Port Orange, FL
  • Trial Date: December 2018 (Ongoing)

This trial evaluates radiofrequency for the treatment and reduction of acne scarring in patients aged 22 years and older

Join Clinical Trial

Common Warts

Warts are a viral infection caused by exposure to the human papilloma virus (HPV). Over 170 subtypes of HPV have been identified. HPV types 1, 2, 4, and 7 are associated with common warts. Wart infections spread from one person to another through Read Moreskin contact (No frogs nor toads are involved). Common warts often resolve without treatment within months once the body’s immunity recognised and destroys the virus. In many patients this immunity fails to develop and warts and persist for months to years. Treatments include destruction of the skin infected through cryosurgery (liquid nitrogen), podophyllotoxin; lasers; or electrosurgery; imiquimod is a topical agent used to enhance the immune response to the virus. New treatment are under development of those patient who despite these options fail to respond or cannot tolerate these treatments. https://www.dermnetnz.org/topics/sexually-acquired-human-papillomavirus; https://www.aad.org/public/diseases/contagious-skin-diseases/warts

  • Age Group: 2 and Older
  • Fort Washington, PA
  • Trial Date: December 2018 (Ongoing)

This trial is for the treatment of common warts for patients that are two years of age or older. The study will last 182 days.

Join Clinical Trial

Psoriasis

Psoriasis is a chronic inflammatory skin condition associated with red thick scaling. It can occur in children and adults. When mild, psoriasis can be treated with topical steroids. When more severe various oral and injectable medications are available. Read MoreMultiple new treatments are in clinical trials. Psoriasis is often associated with psoriatic arthritis, metabolic syndrome, diabetes and cardiovascular disease. The severity of psoriasis is associated with body mass, tobacco exposure and drinking alcohol. For more information: https://www.dermnetnz.org/topics/psoriasis ; https://www.aad.org/public/diseases/scaly-skin/psoriasis; https://www.psoriasis.org/

  • Age Group: 18 and Older
  • Ormond Beach, FL
  • Trial Date: October 2018 (Ongoing)

This trial involves study medication versus active comparator. Participants include patients aged 18 and older with moderate to severe plaque psoriasis. It will be a 52-week multicenter, randomized, double-blind study.

Join Clinical Trial
  • Age Group: 18 and Older
  • Ormond Beach, FL
  • Trial Date: June 2018 (Ongoing)

This trial encompasses comparing study drug versus active comparator. It will involve 44 weeks of treatment for patients aged 18 or older with moderate to severe chronic plaque psoriasis.

Join Clinical Trial
  • Age Group: 18 and Older
  • Ormond Beach, FL
  • Trial Date: October 2018 (Ongoing)

This trial is for patients with moderate to severe plaque psoriasis who weigh 90 kg (198 lb) or higher, who are 18 years of age of older. All patients will received the medication. The study is for 16 weeks with a long-term extension up to a year.

Join Clinical Trial